PYLERA

Medicinal product

(Invented) name

PYLERA

Active substance (s)

Bismuto kalio subcitratas/Metronidazolas/Tetraciklino hidrochloridas

Strength

140 mg/125 mg/125 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

A02BD08, Bismuth subcitrate, tetracycline and metronidazole

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-08-31

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Bismuto kalio subcitratas	140 mg
Metronidazolas	125 mg
Tetraciklino hidrochloridas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122251	108363	1108363	buteliukas	N120		Receptinis	LT/L/26/3574/001	Tiekiama	2026-10-29	-	No	-	-	Download

Stadijos

Data	Stadija
2026-08-31	Registruotas